Greater Noida, India

Naveen Chandra Srivastav

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Assia Chemical Industries Ltd.. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naveen Chandra Srivastav. Retrieved from https://idiyas.com/inventor/naveen-chandra-srivastav

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Naveen Chandra Srivastav

Introduction

Naveen Chandra Srivastav is a notable inventor based in Greater Noida, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid-state forms of Ivosidenib. With a total of 2 patents to his name, his work is recognized for its potential impact on drug formulation and delivery.

Latest Patents

Naveen's latest patents focus on the solid-state forms of Ivosidenib. These patents disclose processes for the preparation of these forms, as well as pharmaceutical compositions and their uses. His innovative approach aims to enhance the efficacy and stability of this important pharmaceutical compound.

Career Highlights

Naveen Chandra Srivastav is currently associated with Assia Chemical Industries Ltd., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to improving drug formulations and ensuring better therapeutic outcomes for patients.

Collaborations

Some of Naveen's notable coworkers include Anantha Rajmohan Muthusamy and Amit Singh. Their collaborative efforts contribute to the innovative environment at Assia Chemical Industries Ltd., fostering advancements in pharmaceutical sciences.

Conclusion

Naveen Chandra Srivastav's contributions to the field of pharmaceuticals through his patents on Ivosidenib exemplify the importance of innovation in drug development. His work not only enhances the understanding of solid-state forms but also paves the way for future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…